Please login to the form below

Not currently logged in


This page shows the latest iPierian news and features for those working in and with pharma, biotech and healthcare.

AbbVie and C2N take tau antibody into clinic

AbbVie and C2N take tau antibody into clinic

Last year, Bristol-Myers Squibb bought into the field via a $725m deal to acquire iPierian.

Latest news

  • BMS buys Alzheimer's player iPierian in $725m deal BMS buys Alzheimer's player iPierian in $725m deal

    In addition to the tau-targeted pipeline, BMS will also tap into iPierian's expertise in disease models, which grew out of earlier work on stem cells. ... BMS has paid $175m upfront for iPierian, with the potential for additional development and

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....